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Abstract 
BACKGROUND: Surgical site infection is one of the major health-care-associated problems causing substantial 
morbidity and mortality and constituting a financial burden on hospitals as well. The wound management is one of 
the crucial evidence-based strategies in the reduction of surgical site infection rates 
AIM: To study the impact of standardisation of transparent semipermeable dressing procedure on the rate of 
surgical site infection in comparison with conventional dressing in clean and clean-contaminated surgeries. 
METHODS: The study included 100 patients who were admitted to surgical wards in Cairo university hospitals, for 
clean and clean-contaminated operations, in the period from February 2017 to August 2017. 
Immunocompromised and uncontrolled diabetic patients were excluded. Patients were randomly allocated into 
two groups; in the first group, patients wounds were covered using transparent semipermeable dressing, while the 
second group patients’ wounds were covered using conventional occlusive gauze dressing. Patients were 
followed up for criteria of infection every other day during the first week then at two weeks, three weeks and four 
weeks. 
RESULTS: In clean and clean-contaminated operations, the transparent dressing group showed a significantly 
lesser rate of surgical site infection at (2%), compared with the conventional occlusive gauze dressing group with 
a surgical site infection rate of (14%) (p-value of 0.02). 
CONCLUSION: The transparent semipermeable dressing is effective in reducing surgical site infection rate in 
clean and clean-contaminated operations. 
 
 
 
 
Introduction 
 
Surgical site infections (SSIs) are those 
occurring in a surgically created wound within 30 
days. SSIs are the commonest hospital-acquired 
infections. They represent a significant burden on the 
health care system worldwide with significant patient 
comorbidity and mortality. The human and financial 
costs of treating surgical site infections (SSIs) are 
rising. It is estimated that approximately half of SSIs 
are deemed preventable using evidence-based 
strategies [1], [2]. 
The Centers for Disease Control and 
Prevention (CDC) classified SSI to superficial; within 
the skin and subcutaneous fat, deep; musculo-facial 
layers or organ space; in an organ or cavity, if 
breached during surgery [3]. 
Different classifications of risk factors have 
been proposed to be associated with SSIs. They can 
be classified to Preoperative, intraoperative and 
postoperative risk factors. SSI risk factors can also be 
divided into modifiable, e.g. cigarette smoking and 
non-modifiable as extreme of age and severity of 
illness [4]. 
In developing countries, the distribution of 
Hospital-acquired infections is different from more 
developed, with fewer bloodstream infections since 
fewer devices are used and a higher proportion of 
SSIs; which can be redeemed preventable through 
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evidence-based measures [5]. 
SSI (defined using Centers for Disease 
Control and Prevention’s National Healthcare Safety 
Network criteria) is defined as infection that occurs 
within 30 days after any operative procedure (where 
day 1 = the procedure date) and patient has at least 
one of the following: purulent drainage, organisms 
identified from an aseptically-obtained specimen from 
the incision by a culture or non-culture based 
microbiologic testing method [1]. The incision that is 
deliberately opened by a surgeon, and the patient has 
at least one of the following signs or symptoms: pain 
or tenderness; localised swelling; erythema; or heat 
and diagnosis of incisional SSI by the surgeon or 
attending physician [1].  
In 11 Egyptian hospitals, 510 SSIs were 
identified following 4,246 surgeries with overall SSI 
rate of 12% [6]. The incidence of SSI at Cairo 
university hospitals was 9.2%. A significant increase 
was associated with a prolonged preoperative hospital 
stay, prolonged surgery, contaminated wounds and 
presence of the drain. The most common organism 
was Staphylococcus aureus (24.3%) then Klebsiella 
pneumonia (18.5%) [7]. 
Good wound care will minimise the 
inflammatory response, speed healing and minimize 
scarring. A dressing is a sterile pad or compresses 
applied to a wound to promote healing and/or prevent 
further harm. Most of the procedures result in wounds 
in which the edges are brought together to heal using 
stitches, staples, clips or glue to allow healing by 
primary intention. Afterwards, wounds are often 
covered with a dressing that acts as a barrier between 
them and the outside environment. One advantage of 
this may be to protect the wound from micro-
organisms, and thus infection. Many different dressing 
types are available for use on surgical wounds [8]. 
The clean wound is an uninfected operative 
wound in which no inflammation is encountered, and 
the respiratory, alimentary, genital, or uninfected 
urinary tracts are not entered, and clean wounds are 
primarily closed. While Clean-Contaminated wounds 
are operative wounds in which the respiratory, 
alimentary, genital, or urinary tracts are entered under 
controlled conditions and without unusual 
contamination [1]. 
Low adherence dressings and wound contact 
materials are usually cotton pads that are placed 
directly in contact with the wound. They are either 
non-medicated (e.g. paraffin gauze dressing), or 
medicated (e.g. containing povidone-iodine or 
chlorhexidine) [9]. 
Transparent film dressings are semi-
permeable membrane dressings; that is waterproof 
yet permeable to oxygen and water vapour which help 
in preventing bacterial contamination. They may be 
used as a primary or secondary dressing. They also 
maintain a humid wound environment, facilitate cell 
migration and encourage necrotic tissue autolysis by 
trapping moisture on the surface of the wound [10], 
[11]. 
The main aim is to study the impact of 
standardisation of transparent semipermeable 
dressing procedure on the rate of surgical site 
infection in comparison with a conventional occlusive 
gauze dressing. 
 
 
Methodology 
 
The study included 100 patients who were 
admitted to surgical wards in Cairo university 
hospitals, during the period between February 2017 to 
August 2017.  
This study was revised and approved by the 
research ethics committee, Faculty of Medicine, Cairo 
University. The study was designed as a randomised 
controlled trial in which patients were allocated to two 
different groups, according to the chronological order 
of their presentation, to A and B; group A patients 
received the transparent dressings for their surgical 
wounds and group B patients had the conventional 
occlusive gauze dressings. 
Patients were then assessed for eligibility 
according to the inclusion and exclusion criteria listed 
below. Patients were informed of the nature of the 
study, consented to participate. 
 
Inclusion criteria 
- Patients who presented to the plastic and 
general surgery department in the study period. 
- Patients with clean surgeries. 
- Patients with clean-contaminated surgeries. 
 
Exclusion criteria 
- Extremes of age; children under the age of 
10 and adults beyond the age of 60. 
- Patients with uncontrolled diabetes. 
- Immuno-compromised patients. 
- Any patient with a history of impaired 
healing. 
- Patients on medication that may impede 
wound healing or render them susceptible to infection 
(eg. Steroids) 
- Patient with contaminated or infected 
surgery. 
- Patients presenting in the trauma 
department. 
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- Drop-outs from follow up. 
Group A: Included fifty patients’ undergone 
different clean and clean-contaminated surgeries, and 
received postoperative semipermeable transparent 
wound dressing since day one and throughout their 
postoperative course. 
 
Figure 1: Gauze dressing covering abdominal incision 
postoperatively 
  
Group B: Included fifty patients’ undergone 
different clean and clean-contaminated surgeries, and 
received conventional occlusive gauze dressings 
since day one and throughout their postoperative 
course. 
 
Figure 2: Transparent dressing covering incision postoperatively 
 
 The following data were collected from 
patients upon enrollment in the study: - Full medical 
history analysis including age, sex, cigarette smoking 
and medical comorbidities, regular medications that 
may impede healing and drug allergies; - Operative 
details including the use of any foreign material and 
previous surgical history; - Full general examination 
including body weight, vital signs, and skin conditions 
preceding the surgical operation; - Preoperative 
investigations including complete blood picture, 
fasting blood glucose and HbA1c; and - Preoperative 
prophylaxis was done according to hospital policy; 
ampicillin-sulbactam was given within minutes to one 
hour before incision. One dose was sufficient, yet 
additional doses were given for operating procedures 
longer than three hours. 
 
Follow up and criteria of infection 
Wounds were evaluated postoperatively every 
other day in the first week then weekly till the end of 
the month. 
Group A: transparent wound dressings were 
applied intraoperatively. Afterwards, they were 
evaluated for adherence, underlying exudate, and 
transparency and stigmata of infection, and were only 
changed when a leak was detected or lost adherence. 
Under aseptic conditions, films were removed, and the 
wounds were cleaned with normal saline, and 
povidone-iodine was used as a disinfectant and 
allowed to dry, and a new film was reapplied. 
Group B: basic gauze dressing was used 
intraoperatively, with every other day, dressing 
changes starting from day 2 postoperatively till the 
third week. The dressings were removed, the wounds 
were inspected and cleansed with saline, povidone-
iodine was applied, and the wound was covered with 
gauze followed by adhesive plaster. 
The equation to calculate rates of SSIs: 
No. of SSIs in a specific group X 100 
No. of operations in the same group 
 
Microbiological analysis for patients with 
suspected wound infection: Using a sterile technique, 
a sterile cotton-wool swab was used to collect a 
sample from the infected site. 
Sample processing: All samples were cultured 
on blood MacConkey agar incubated aerobically at 
37°C for 24-48 hrs. Direct Gram-stained films were 
prepared from each wound swab and examined 
microscopically. Identification of isolated 
microorganisms according to standards using: Gram 
stain, colony morphology, Biochemical reactions for 
gram-positive isolates (catalase, coagulase, mannitol, 
DNase). Also, novobiocin disc was used for further 
identification of Staphylococci. Biochemical reactions 
for gram-negative isolates (TSI, LIA, MIO, citrate, 
urease, and oxidase). Antimicrobial susceptibility was 
done by disk diffusion method. 
 
Statistical Method 
Data were analysed using SPSS win 
statistical package version 20 (SPSS Inc., Chicago, 
IL). Numerical data were expressed as mean and 
standard deviation or median and range as 
appropriate. Qualitative data were expressed as 
frequency and percentage. Chi-square test (Fisher’s 
exact test) was used to examine the relation between 
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qualitative variables. For quantitative data, a 
comparison between the two groups was made using 
either student t-test or Mann-Whitney test (non-
parametric t-test) as appropriate. A p-value < 0.05 
was considered significant.  
 
 
Results 
 
The age of the patients included in group A 
ranged from 15 – 55 years, with a mean of 34 ± 10.02. 
The age of the patients included in group B ranged 
from 18 – 57 years with a mean of 34.46 ± 9.157. 
Group A included 40 females (80%) and 10 males 
(20%), while group B included 41 females (82%) and 
9 males (18%) as shown in Table 1. 
Table 1: Patients’ baseline demographics and wound 
characteristics 
 Group A 
Transparent dressing 
Group B 
Conventional dressing 
Age: 
Y Mean (SD*) 
 
34 (10.022) 
 
34.46 (9.157) 
Sex in (percent %): 
Male 
Female 
 
20% 
80% 
 
18% 
82% 
Risk factors (per cent %): 
Obesity 
Smokers 
 
42% 
4% 
 
34% 
6% 
Type of wounds: 
Clean 
Clean-contaminated 
 
44 
6 
 
44 
6 
* Denotes standard deviation. 
 
Our findings confirm that the rate of SSI is 
lower when transparent dressings were used on 
surgical incisions when compared to the conventional 
occlusive gauze dressing, as shown in Table 2 and 3, 
(p-value 0.02). 
 
Figure 3: Types of operations in a transparent dressing group 
 
To study obesity as a risk factor of SSI, we 
found that of the 100 patients, 38 % were obese, and 
62% were non-obese. Of the 38 patients suffering 
from Obesity, 6 had SSI which is 15.7%, while those 
are not suffering from Obesity only 2 out of 62 patients 
suffered from SSI with 3.2% only. (p-value < 0.02) 
which is statistically significant. 
 
Figure 4: Types of operations in a conventional dressing group 
 
Age of the patients included in our study 
ranged from 15 – 57 years, with a mean of 34 ± 9.579. 
Mean age in the infected group was 37.2 ± 9.7 in 
comparison to 33.9 ± 9.5 in the non-infected group. 
 
Figure 5: showing infected wound postoperatively after 
abdominoplasty operation 
 
The incidence of smoking as a risk factor 
among both groups was 5%. Such an incidence was 
not high enough to reliably assess the impact of 
smoking as a risk factor of SSI.  
Table 2: Comparison between Transparent dressing and 
Conventional dressing 
 Dressing type  
Transparent dressing Conventional dressing P value 
Number % Number % 
Age (Mean ± SD*) 34 ± 10  34.5 ± 9.2  0.81 
Sex 
       
Male 10 52.6% 9 47.4% 0.79 
Total 
 
50 50.0% 50 50.0%  
Obesity 
      
Yes 21 55.2% 17 44.7 % 0.5 
Total 
 
50 50.0% 50 50.0%  
Smoking 
      
Yes 2 40.0% 3 60.0% 0.65 
Total 
 
50 50.0% 50 50.0%  
Type of wound 
Clean 44 50.0% 44 50.0%  
clean contaminated 6 50.0% 6 50.0% 1 
Total 
 
50 50.0% 50 50.0%  
Infection group 
      
Infected 1 12.5% 7 87.5% 0.02 
Total 50 50.0% 50 50.0%  
* Denotes standard deviation. 
 
 
 
Follow up 
The transparent dressing stayed in place for a 
mean of 6 days (range 5 – 7), and the gauze dressing 
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was removed after a mean of 1.5 days (range 1 – 3). 
The transparent dressing, therefore, stayed in place, a 
mean of four and a half days longer than the gauze 
dressing. 
 We gained the impression that the patient’s 
comfort and well-being were better in the transparent 
group as it made bathing possible and allowed earlier 
postoperative mobilisation. 
Table 3: Comparison between infected and non-infected 
groups 
 Non-Infected Infected P-value 
Number % number % 
Age (Mean ± SD*) 33.9 ± 9.5  37.2 ± 9.5  0.33 
 Sex 
 
 
 Obesity 
 
 
Smoking 
Male 19 20.6% 0 0.0% 0.15 
Total 
 
92 92.0% 8 8.0%  
Yes 32 34.7% 6 15.7% 0.02 
Total 
 
92 92% 8 8.0%  
Yes 5 100.0% 0 0.0% 0.49 
Total 
 
92 92.0% 8 8.0%  
Total leucocytic 
count 
High 7 87.5% 1 12.5% 0.62 
Total 
 
92 92.0% 8 8.0%  
Type of wound 
Clean 80 90.9% 8 9.0%  
clean contaminated 12 100.0% 0 0.0%  
Total 
 
92 92.0% 8 8.0% 0.27 
Dressing type 
Transparent dressing 49 98.0% 1 2.0%  
Conventional dressing 43 86.0% 7 14.0% 0.02 
Total 92 92.0% 8 8.0%  
* Denotes standard deviation. 
 
The patients with transparent dressing felt 
more satisfied as the dressing was conformable, and 
the frequency of dressing change was less than the 
gauze dressing. 
 Inspection of the wound through the 
transparent dressing was transparent in 24 patients 
(48%), slightly opaque in 11 patients (22%) but the 
sutures could be seen, and 15 (30%) were opaque 
that the sutures couldn’t be seen and the dressing 
was replaced to visualise the sutures.  
 
Figure 6: Frequency of various pathogens causing surgical site 
infections in the conventional group 
 
The TLC was elevated among 7 patients 14% 
in the conventional dressing group and 1 patient 2% in 
the transparent dressing group (p-value < 0.03) 
Table 4: Frequency of pathogens causing surgical site 
infections in patients with occlusive transparent dressing 
group
 
 Frequency Per cent Per cent 
negative culture 1 2.0 100.0 
Total 1 2.0 100.0 
Discussion 
 
 In this study, our goal was to evaluate the 
impact of a transparent semipermeable film dressing 
versus the conventional occlusive gauze dressing on 
rates of SSIs in the period of February 2017 to August 
2017. 
The age of the patients included in the study 
ranged from 15 – 57 years, with a mean of 34 ± 9.579. 
The mean age in the infected group was 37.2 ± 9.7 
compared to non-infected group 33.9 ± 9.5 in the non-
infected group (p-value 0.33). However, the mean age 
was higher in the study conducted by C. Holm et al., 
1998 which was 61.3, (range 25 – 90) years, and also 
in the study conducted by Shinohara et al., 2008 the 
mean age was 63.5 years (range 31 – 91 years) [12], 
[13]. This may be due to the conduction of our study in 
a developing country where the mean age of the 
general population is lower than that where C. Holm 
and Shinohara conducted their study. Also, this could 
be attributed to the fact that we excluded patients 
above the age of 60 years old. 
 Our study included 81 females and 19 males, 
which differs from the studies conducted by C. Holm 
et al., 1998 and by Shinohara et al., 2008 which 
included equal numbers of males and females. While 
the study conducted by Ubbink et al., 2008 included 
92 males and 50 females in the transparent dressing 
group and 93 males and 50 females in the 
conventional dressing group [12], [13], [14]. That 
difference, in our opinion, had no effect on the results 
of our study. This larger number of female patients 
involved in this study might be since females are more 
prone to go for plastic procedures. Also, on a national 
level, the female's super number the males which 
make our finding sensible. 
In our study, the type of wound dressing used 
had an influence on the rate of SSI; this influence was 
found to be statistically significant. One patient (2%) of 
a total of 50 patients who had used transparent 
semipermeable wound dressing suffered from SSI, 
compared to seven patients (14%) of a total of 50 
patients suffered from SSI in the other group that used 
conventional occlusive gauze dressing. This shows 
the superiority of transparent semipermeable wound 
dressing usage following elective clean and clean-
contaminated surgical procedures in reducing the rate 
of SSI (p-value 0.02). 
Collated data from 50 controlled trials on a 
variety of wounds yielded infection rates of 5.37% and 
3.25% rates (p < 0.001) between conventional gauze 
and transparent dressings, respectively [15].  
In a study conducted by Maki and Ringer 
1987, Cutaneous colonisation using transparent 
dressing was lower in level and comparable with a 
gauze dressing and other dressings (range, 100.58 to 
100.70 colony-forming units) [16]. 
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There is also evidence that moist wound 
healing results in better cosmesis, decreased pain, 
and improvement in the granulation tissue of the 
wound bed [17]. 
This differs from a study conducted by Sastry 
et al., 2015. They implemented the use of sterile 
gauze or a transparent semipermeable dressing to 
cover the wound of cardiac implantable electronic 
devices, with no inclination to the use of any of the 
fore-mentioned types [18].  
This agrees with another study conducted by 
Cosker 2005 showing that there was no statistically 
significant difference in the number of SSIs in the 
basic wound contact-dressed group (5 / 100; 5%), 
compared with the transparent film-dressing group (9 / 
200; 5%) [19]. 
The overall SSI incidence rate in the current 
study was 8 %. Nearly similar findings were concluded 
from a study conducted at Tanta University Hospital in 
Egypt by Afifi and Baghagho, 2010 who detected an 
overall SSI incidence rate of 8.3% [20]. Meanwhile 
lower SSI rates could be detected in France, Italy and 
Germany, SSI rates of 3.3%, 3.3% and 1.2% were 
detected in three studies conducted by Rioux et al., 
2006, Moro et al., 2005 and Hirschmann et al., 2005 
[21], [22], [23]. This could be attributed to the 
conduction of our study in a developing country which 
usually shows higher rates of SSIs than more 
developed countries. 
In the current study, obesity was statistically 
significantly associated with an increased risk of SSI 
(P-value = 0.02). This was like a study of Egyptian 
orthopaedic patients by Abdel-Halim et al., 2010 who 
reported in their study that obesity was a significant 
risk factor for SSI (P < 0.001) [24]. To study obesity as 
a risk factor of SSI, we found that of the 100 patients, 
38% were obese, and 62% were non-obese. 
Incidence of infection in the obese group was 15.7% 
and in the non-obese group was 3.2% (p-value < 
0.02) which is statistically significant. Our study 
detected that the incidence of obesity among the 
transparent dressing group included 21 patients, 42%, 
while among the conventional dressing group included 
17 patients, 34%. 
Our study as well as Shinohara et al., 2008 
gained the expression that Patients seemed more 
comfortable with the transparent dressings, which 
allowed them to move about freely and to take a 
shower when necessary and early postoperative 
mobilization was also facilitated, and studies 
suggested that film dressings might be less painful for 
patients than basic wound contact dressings [13]. 
AS for the SSI microbiology in our study, the 
organisms isolated from the infected wounds from the 
transparent dressing group: negative culture 2%. 
Organisms isolated from the infected wounds gauze 
dressing group: negative culture 8%, E-coli 2%, 
Klebsiella 2%, Serratia 2%. This differs from results of 
a study conducted in Japan by Shinohara published in 
2008 showing the isolation of Bacteroides fragilis 
(3/63) 4.8% in transparent dressing group and 
isolation of Bacteroides fragilis and Enterococcus 
faecalis (4/71) 5.6% in gauze dressing group (p = 
0.567) [13]. Staph aureus was the main causative 
organism of SSI (44.4%), all S. aureus isolates were 
MRSA, followed by Klebsiella pneumoniae 22/90 
(24.44%) and Acinetobacter 15/90 (16.67%). The 
implant was highly associated with SSI cases 80 / 90 
(89%) according to Helal et al., 2015 [25]. 
One of the limitations encountered during our 
study was negative cultures despite the presence of 
SSI that was diagnosed by the surgeons and 
according to the CDC criteria for SSI. The appearance 
of postoperative SSI in the absence of culturable 
bacterial pathogens is a common dilemma for 
surgeons. The potential causes of culture-negative 
SSI include prior antimicrobial therapy, the presence 
of fastidious or slow-growing microorganisms or 
infection caused by ordinary bacteria that may be 
dismissed as “contaminants” and performing aerobic 
cultures only [26]. Other limitations in our study 
included a lower number of clean-contaminated 
surgeries in our study in comparison to clean 
surgeries. 
In conclusion, our study showed that the 
transparent semipermeable dressing is effective in 
reducing surgical site infection rate in clean and clean-
contaminated operations as well as, reducing its 
burdens as additional hospital stay and additional 
costs associated with the occurrence of infection. 
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